[Federal Register Volume 59, Number 31 (Tuesday, February 15, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-3570]


[[Page Unknown]]

[Federal Register: February 15, 1994]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Parts 123 and 1240

 

 Food Safety Initiative; Notice of Public Meetings

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meetings.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration's (FDA) is announcing that it 
is sponsoring nine public meetings that are intended to promote 
understanding of FDA's recently announced food safety initiative. This 
initiative includes the Food Code and the proposal to require that 
domestic seafood processors, importers, and foreign processors who 
export seafood to the United States establish hazard analysis critical 
control point (HACCP) systems to ensure the safety of their products. 
FDA is holding these meetings to facilitate informed public comment on 
the seafood HACCP proposal.

DATES: For meeting dates, see Table 1 in ``Supplementary Information.''

ADDRESSES: For meeting addresses, see Table 1 in ``Supplementary 
Information.''

FOR FURTHER INFORMATION CONTACT:  Edward A. Steele (or the local 
contact person listed in Table 2 in ``Supplementary Information''), 
Office of Seafood, Center for Food Safety and Applied Nutrition (HFS-
405), Food and Drug Administration, 200 C St. SW., Washington, DC 
20204, 202-254-3885.

SUPPLEMENTARY INFORMATION: FDA's food safety initiative was announced 
by Donna E. Shalala, Secretary of Health and Human Services, on January 
21, 1994. This initiative includes the proposal to require that 
domestic seafood processors, importers, and foreign processors who 
export seafood to the United States employ hazard analysis critical 
control point (HACCP) systems in their processing of food to ensure the 
safety of their products to consumers (59 FR 4142, January 28, 1994).
    To promote understanding of the food safety initiative, FDA is 
holding nine public meetings. At each meeting, the proposed HACCP 
regulation will be explained, and time will be provided to answer 
questions from the public about the proposal. By holding these public 
meetings, the agency is hoping to facilitate the development of public 
comments for consideration in the development of the HACCP final rule. 
The purpose of these meetings is not, however, to receive comments.
    The food safety initiative also includes the issuance of the Food 
Code, which provides a model for those Federal, State, and local 
jurisdictions that have regulatory responsibility for food service, 
retail, and vending operations. The Food Code provides a framework for 
the application of HACCP at the retail level. Agency personnel will be 
present at these meetings to provide an overview of the Food Code.
    The meetings will be held at the addresses and on the dates listed 
in Table 1 as follows:

                                 Table 1                                
------------------------------------------------------------------------
           Meeting addresses                          Dates             
------------------------------------------------------------------------
Stouffer Harbor Place Hotel, 202 East                                   
 Pratt St., Baltimore, MD                                               
                                        February 22, 1994               
Wyndham Hamilton Hotel, 400 Park                                        
 Blvd., Itasca, IL                                                      
                                        February 25, 1994               
The LaGuardia Marriott, 102-05 Ditmars                                  
 Blvd., East Elmhurst, NY                                               
                                        March 2, 1994                   
Radisson Mart Plaza Hotel, 711 NW.,                                     
 72d Ave., Miami, FL                                                    
                                        March 3, 1994                   
Westin Hotel, 100 Iberville St., New                                    
 Orleans, LA                                                            
                                        March 4, 1994                   
Hyatt Regency Hotel, 6225 W. Century                                    
 Blvd., Los Angeles, CA                                                 
                                        March 7, 1994                   
Seattle Center, Olympic Room, 305                                       
 Harrison St., Seattle, WA                                              
                                        March 8, 1994                   
Regal Alaskan Hotel, 4800 Stenard Rd.,                                  
 Anchorage, AK                                                          
                                        March 10, 1994                  
The Hynes Convention Center, rm. 100,   March 16, 1994                  
 900 Boylston St., Boston, MA                                           
------------------------------------------------------------------------

    Meetings will be held from 1 p.m. to 4:30 p.m. Evening sessions, 
which will be held from 7 p.m. to 8:30 p.m., are scheduled in all 
cities, except Chicago (Itasca), Anchorage, and Boston. The evening 
sessions in Baltimore, New York, Miami, New Orleans, Los Angeles, and 
Seattle are being scheduled to accommodate those unable to attend the 
afternoon sessions. Evening sessions will be limited to questions and 
answers only.

    There is no charge to attend these meetings. Advance registration 
is requested. Early registration is suggested because space is limited. 
The deadline for registering is 1 week before each meeting. Late 
registration will be accepted pending availability of space. Those 
persons interested in attending should fax their name, organization, 
address, telephone number, and session of interest (afternoon or 
evening) to the local contact persons listed in Table 2 as follows: 

                                Table 2                                 
------------------------------------------------------------------------
         Meeting location                      Contact person           
------------------------------------------------------------------------
Baltimore........................  Alexander A. Ondis, Baltimore        
                                    District Office, FDA, 900 Madison   
                                    Ave., Baltimore, MD 21201, 410-962- 
                                    3590 or FAX 410-962-2307.           
                                                                        
Chicago..........................  Maxine Aubert, Chicago District      
                                    Office, FDA, 300 South Riverside    
                                    Plaza, suite 550 South, Chicago, IL 
                                    60606, 312-353-7379 or FAX 312-886- 
                                    3280.                               
                                                                        
New York.........................  Joseph C. Famulare, New York         
                                    District, FDA, Long Island Resident 
                                    Post, 6800 Jericho Turnpike, suite  
                                    109E, Syosset, New York 11791, 516- 
                                    921-2869 or FAX 516-921-3025.       
                                                                        
Miami............................  Lynne C. Issacs, Orlando District    
                                    Office, FDA, 7200 Lake Ellenor Dr., 
                                    suite 120, Orlando, FL 32809, 407-  
                                    648-6922 or FAX 407-648-6221.       
                                                                        
New Orleans......................  Tura King, New Orleans District      
                                    Office, FDA, 4298 Elysian Fields,   
                                    New Orleans, LA 70122, 504-589-4334 
                                    or FAX 504-589-4365.                
                                                                        
Los Angeles......................  Yvonne Banegas, Los Angeles District 
                                    Office, FDA, 1521 West Pico Blvd.,  
                                    Los Angeles, CA 90015, 213-252-7586 
                                    or FAX 213-251-7148.                
                                                                        
Seattle..........................  Sue Hutchcroft, Seattle District     
                                    Office, FDA, 22201 23d Dr. SE.,     
                                    Bothell, WA 98041, 206-483-4999 or  
                                    FAX 206-483-4996.                   
                                                                        
Anchorage........................  Sue Hutchcroft, Seattle District     
                                    Office, FDA, 22201 23d Dr. SE.,     
                                    Bothell, WA 98041, 206-483-4999 or  
                                    FAX 206-483-4996.                   
                                                                        
Boston...........................  Alyson L. Saben, Boston District     
                                    Office, FDA, One Montvale Ave.,     
                                    Stoneham, MA 02180, 617-279-1675,   
                                    ext. 118 or FAX 617-279-1742.       
------------------------------------------------------------------------


    Dated: February 10, 1994.
Michael R. Taylor,
Deputy Commissioner for Policy.
[FR Doc. 94-3570 Filed 2-11-94; 9:37 am]
BILLING CODE 4160-01-F